Table 2.
Diagnosis, radiology, history, PUFA supplementation, and cognitive results. Patients are listed by accession number and show clinical diagnosis (Dx), radiology (PET and MRI), history and symptoms, cholinesterase inhibitor (CI) (Aricept) and NMDA blocker (Namenda) therapy, MMSE score at the first and the last visit, onset of dementia, and duration of PUFA supplementation by the SmartfishR drink (SMF) (months)
| Subjective Cognitive Impairment | |||||||||
| Months on AD Therapy | MMSE Score | ||||||||
| Pt # | Dx | Radiology | History | CI | NMDA | First Visit | Last Visit | Onset of Dementia (mo p onset) | PUFA supplement (mo) |
| 8 | SCI | N/D | Memory loss | 0 | 0 | 30 | 30 | neg | 24 |
| 10 | SCI | N/D | Memory loss, familial alcoholism | 0 | 0 | 29 | 30 | neg | 24 |
| 18 | SCI | N/D | Concussion, low exec. function | 2 | 2 | 30 | 30 | neg | 56 |
| Mild Cognitive Impairment (MCI) | |||||||||
| 22 | MCI | N/D | Memory loss | 24 | 24 | 22 | 24 | neg | 25 |
| 28 | MCI | No stenosis (MRA) | Memory loss | 24 | 0 | 16 | 25 | neg | >19 |
| MCI/Vascular Cognitive Impairment (VCI) | |||||||||
| 2 | VCI | Regional hypo metabolism (PET) | Repeated minor strokes | 0 | 24 | 24 | 27 | Neg | 44 |
| 14 | VCI | Post cingulate hypometabolism (PET) | Repeated minor strokes | 24 | 0 | 25 | 27 | 60 | 49 |
| 37 | VCI | Assymetric temporal hypometabolism | Depression | 0 | 0 | 30 | 30 | Neg | 36 |
| Dementia with Lewy Bodies (DLB)/ VCI | |||||||||
| 9 | DLB | Cortical hypometabolism (PET) | Paranoia | 0 | 0 | 26 | 25 | 24 | 22 |
| 33 | DLB | Parieto-temporal, cingulate and visual cortex hypometabolism (PET) | Major depression | 12 | 12 | 26 | 30 | Neg | 36 |